Logo image of BLKB

BLACKBAUD INC (BLKB) Stock Fundamental Analysis

NASDAQ:BLKB - Nasdaq - US09227Q1004 - Common Stock - Currency: USD

65.73  +1.08 (+1.67%)

After market: 65.73 0 (0%)

Fundamental Rating

3

BLKB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. There are concerns on the financial health of BLKB while its profitability can be described as average. BLKB has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BLKB was profitable.
In the past year BLKB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BLKB reported negative net income in multiple years.
In the past 5 years BLKB always reported a positive cash flow from operatings.
BLKB Yearly Net Income VS EBIT VS OCF VS FCFBLKB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

BLKB has a worse Return On Assets (-11.35%) than 61.48% of its industry peers.
BLKB has a worse Return On Equity (-199.43%) than 82.69% of its industry peers.
BLKB has a better Return On Invested Capital (8.57%) than 82.69% of its industry peers.
Industry RankSector Rank
ROA -11.35%
ROE -199.43%
ROIC 8.57%
ROA(3y)-4.27%
ROA(5y)-2.45%
ROE(3y)-68.43%
ROE(5y)-40.54%
ROIC(3y)N/A
ROIC(5y)N/A
BLKB Yearly ROA, ROE, ROICBLKB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 11.67%, BLKB belongs to the top of the industry, outperforming 80.57% of the companies in the same industry.
In the last couple of years the Operating Margin of BLKB has grown nicely.
BLKB has a worse Gross Margin (55.32%) than 64.66% of its industry peers.
In the last couple of years the Gross Margin of BLKB has remained more or less at the same level.
Industry RankSector Rank
OM 11.67%
PM (TTM) N/A
GM 55.32%
OM growth 3Y55.49%
OM growth 5Y26.14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.94%
GM growth 5Y0.66%
BLKB Yearly Profit, Operating, Gross MarginsBLKB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLKB is destroying value.
The number of shares outstanding for BLKB has been reduced compared to 1 year ago.
Compared to 5 years ago, BLKB has more shares outstanding
The debt/assets ratio for BLKB is higher compared to a year ago.
BLKB Yearly Shares OutstandingBLKB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BLKB Yearly Total Debt VS Total AssetsBLKB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

BLKB has an Altman-Z score of 1.29. This is a bad value and indicates that BLKB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 1.29, BLKB perfoms like the industry average, outperforming 41.70% of the companies in the same industry.
The Debt to FCF ratio of BLKB is 4.70, which is a neutral value as it means it would take BLKB, 4.70 years of fcf income to pay off all of its debts.
BLKB has a Debt to FCF ratio (4.70) which is in line with its industry peers.
BLKB has a Debt/Equity ratio of 7.40. This is a high value indicating a heavy dependency on external financing.
BLKB's Debt to Equity ratio of 7.40 is on the low side compared to the rest of the industry. BLKB is outperformed by 85.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.4
Debt/FCF 4.7
Altman-Z 1.29
ROIC/WACC0.64
WACC13.42%
BLKB Yearly LT Debt VS Equity VS FCFBLKB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.78 indicates that BLKB may have some problems paying its short term obligations.
With a Current ratio value of 0.78, BLKB is not doing good in the industry: 83.75% of the companies in the same industry are doing better.
BLKB has a Quick Ratio of 0.78. This is a bad value and indicates that BLKB is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.78, BLKB is not doing good in the industry: 83.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
BLKB Yearly Current Assets VS Current LiabilitesBLKB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

BLKB shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.03%.
Measured over the past years, BLKB shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.74% on average per year.
The Revenue has been growing slightly by 4.53% in the past year.
Measured over the past years, BLKB shows a small growth in Revenue. The Revenue has been growing by 5.12% on average per year.
EPS 1Y (TTM)3.03%
EPS 3Y10.43%
EPS 5Y12.74%
EPS Q2Q%-5.26%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y7.59%
Revenue growth 5Y5.12%
Sales Q2Q%2.45%

3.2 Future

Based on estimates for the next years, BLKB will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.75% on average per year.
The Revenue is expected to grow by 5.80% on average over the next years.
EPS Next Y6.5%
EPS Next 2Y7.52%
EPS Next 3Y-2.22%
EPS Next 5Y15.75%
Revenue Next Year-3.31%
Revenue Next 2Y0.47%
Revenue Next 3Y2.16%
Revenue Next 5Y5.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BLKB Yearly Revenue VS EstimatesBLKB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
BLKB Yearly EPS VS EstimatesBLKB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.11, BLKB is valued correctly.
BLKB's Price/Earnings ratio is rather cheap when compared to the industry. BLKB is cheaper than 84.45% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. BLKB is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 15.13 indicates a correct valuation of BLKB.
85.87% of the companies in the same industry are more expensive than BLKB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. BLKB is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.11
Fwd PE 15.13
BLKB Price Earnings VS Forward Price EarningsBLKB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

BLKB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLKB is cheaper than 84.81% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLKB is valued cheaply inside the industry as 89.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 14.15
EV/EBITDA 16.54
BLKB Per share dataBLKB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BLKB's earnings are expected to decrease with -2.22% in the coming years. This may justify a cheaper valuation.
PEG (NY)2.48
PEG (5Y)1.26
EPS Next 2Y7.52%
EPS Next 3Y-2.22%

0

5. Dividend

5.1 Amount

No dividends for BLKB!.
Industry RankSector Rank
Dividend Yield N/A

BLACKBAUD INC

NASDAQ:BLKB (3/7/2025, 8:07:54 PM)

After market: 65.73 0 (0%)

65.73

+1.08 (+1.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-18 2025-02-18/bmo
Earnings (Next)04-28 2025-04-28/amc
Inst Owners74.86%
Inst Owner Change-2.16%
Ins Owners1.61%
Ins Owner Change3.17%
Market Cap3.24B
Analysts50
Price Target80.2 (22.01%)
Short Float %1.42%
Short Ratio2.73
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.65%
Min EPS beat(2)-8.95%
Max EPS beat(2)-0.35%
EPS beat(4)2
Avg EPS beat(4)-1.27%
Min EPS beat(4)-8.95%
Max EPS beat(4)2.22%
EPS beat(8)6
Avg EPS beat(8)2.42%
EPS beat(12)9
Avg EPS beat(12)3.02%
EPS beat(16)13
Avg EPS beat(16)5.45%
Revenue beat(2)0
Avg Revenue beat(2)-3.38%
Min Revenue beat(2)-4.32%
Max Revenue beat(2)-2.45%
Revenue beat(4)0
Avg Revenue beat(4)-3.13%
Min Revenue beat(4)-4.32%
Max Revenue beat(4)-2.45%
Revenue beat(8)0
Avg Revenue beat(8)-2.74%
Revenue beat(12)0
Avg Revenue beat(12)-2.5%
Revenue beat(16)2
Avg Revenue beat(16)-1.67%
PT rev (1m)-7.66%
PT rev (3m)-7.66%
EPS NQ rev (1m)-9.06%
EPS NQ rev (3m)-8.83%
EPS NY rev (1m)-8.78%
EPS NY rev (3m)-8.78%
Revenue NQ rev (1m)-7.16%
Revenue NQ rev (3m)-8.69%
Revenue NY rev (1m)-7.31%
Revenue NY rev (3m)-8.57%
Valuation
Industry RankSector Rank
PE 16.11
Fwd PE 15.13
P/S 2.8
P/FCF 14.15
P/OCF 10.94
P/B 22.79
P/tB N/A
EV/EBITDA 16.54
EPS(TTM)4.08
EY6.21%
EPS(NY)4.35
Fwd EY6.61%
FCF(TTM)4.65
FCFY7.07%
OCF(TTM)6.01
OCFY9.14%
SpS23.47
BVpS2.88
TBVpS-21.19
PEG (NY)2.48
PEG (5Y)1.26
Profitability
Industry RankSector Rank
ROA -11.35%
ROE -199.43%
ROCE 10.84%
ROIC 8.57%
ROICexc 9.06%
ROICexgc N/A
OM 11.67%
PM (TTM) N/A
GM 55.32%
FCFM 19.8%
ROA(3y)-4.27%
ROA(5y)-2.45%
ROE(3y)-68.43%
ROE(5y)-40.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y93.05%
ROICexc growth 5Y27.63%
OM growth 3Y55.49%
OM growth 5Y26.14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.94%
GM growth 5Y0.66%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 7.4
Debt/FCF 4.7
Debt/EBITDA 4.1
Cap/Depr 55.23%
Cap/Sales 5.82%
Interest Coverage 2.6
Cash Conversion 115.38%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z 1.29
F-Score6
WACC13.42%
ROIC/WACC0.64
Cap/Depr(3y)61.08%
Cap/Depr(5y)64.81%
Cap/Sales(3y)6.11%
Cap/Sales(5y)6.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.03%
EPS 3Y10.43%
EPS 5Y12.74%
EPS Q2Q%-5.26%
EPS Next Y6.5%
EPS Next 2Y7.52%
EPS Next 3Y-2.22%
EPS Next 5Y15.75%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y7.59%
Revenue growth 5Y5.12%
Sales Q2Q%2.45%
Revenue Next Year-3.31%
Revenue Next 2Y0.47%
Revenue Next 3Y2.16%
Revenue Next 5Y5.8%
EBIT growth 1Y168.03%
EBIT growth 3Y67.3%
EBIT growth 5Y32.6%
EBIT Next Year31.58%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y68.83%
FCF growth 3Y12.31%
FCF growth 5Y13.01%
OCF growth 1Y48.26%
OCF growth 3Y11.47%
OCF growth 5Y10.15%